CSIMarket
 


Axsome Therapeutics Inc   (AXSM)
Other Ticker:  
 

Cumulative Axsome Therapeutics Inc 's Leverage Ratio for Trailing Twelve Months Period

AXSM's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

AXSM Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth 71.27 % 1734.3 % 660.73 % 600.92 % 268.37 %
Y / Y Total Liabilities Growth 82.46 % 101.28 % 275.52 % 207.56 % 145.8 %
Leverage Ratio for Trailing Twelve Months Period 1.51 1.54 2.15 2.17 2.43
Total Ranking # 2281 # 2415 # 2957 # 3406 # 3330
Seq. Equity Growth -3.33 % 149.35 % 2.06 % -30.38 % 935.31 %
Seq. Total Liabilities Growth -0.45 % 20 % 24.99 % 22.2 % 9.82 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to debt repayement of -0.45% Axsome Therapeutics Inc decreased Leverage Ratio for Trailing Twelve Months Period in the III. Quarter to 1.51, below company's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 322 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Axsome Therapeutics Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are AXSM's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 323
Sector # 647
S&P 500 # 2020


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
4.37 1.58 0.3
(Jun 30 2022)   (Sep 30 2020)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Janone Inc   4.05 
Eterna Therapeutics Inc   3.98 
Teva Pharmaceutical Industries Limited  3.92 
9 Meters Biopharma Inc   3.75 
Cellectar Biosciences inc   3.68 
Aditxt Inc   3.63 
Evoke Pharma Inc   3.50 
Palatin Technologies Inc   3.43 
First Wave Biopharma Inc   3.40 
Dar Bioscience Inc   3.39 
Eli Lilly And Company  3.20 
Ascendis Pharma A  3.14 
Bioxcel Therapeutics Inc   3.09 
Sellas Life Sciences Group Inc   2.96 
Paxmedica Inc   2.88 
Mersana Therapeutics Inc   2.77 
China Pharma Holdings Inc   2.70 
Trevena inc   2.62 
Aveo Pharmaceuticals Inc   2.51 
Spectrum Pharmaceuticals Inc   2.49 
Celyad Oncology Sa  2.47 
Aytu Biopharma Inc   2.38 
Exicure Inc   2.34 
Innovation Pharmaceuticals Inc   2.32 
Capricor Therapeutics inc   2.31 
Phibro Animal Health Corporation  2.27 
Immunome Inc  2.23 
Albireo Pharma inc   2.21 
Apellis Pharmaceuticals Inc   2.19 
Chembio Diagnostics Inc   2.19 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com